Nutrition in oncologic patients during antiblastic treatment

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Massimiliano Berretta^1,*, Mariagrazia Michieli¹, Raffaele Di Francia², Alessandro Cappellani³, Maurizio Rupolo¹, Fabio Galvano⁴, Rossella Fisichella³, Salvatore Berretta³, Umberto Tirelli¹

Show Less

¹ Department of Medical Oncology, National Cancer Institute Aviano (Pn), Italy

² Laboratory of Molecular Hematology, National Cancer Institute, G. Pascale, Naples, Italy

³ Department of Surgery, University of Catania, Catania, Italy

⁴ Department of Biological Chemistry, Medical Chemistry, Molecular Biology, University of Catania, Catania, Italy

Front. Biosci. (Landmark Ed) 2013, 18(1), 120–132; https://doi.org/10.2741/4091

Published: 1 January 2013

Download PDF

Cite

Abstract

Cancer may induce weight loss and cachexia, and cancer treatment may contribute to nutritional impairment. Here, we review the literature on the mechanisms of cancer cachexia and the pharmacological interventions both in use in clinical practice and currently under development. Based on this analysis, several nutritional proposals for cancer patients are suggested and the importance of good nutritional status in candidates for hematopoietic stem cell transplantation is highlighted.

Keywords

Antiblastic chemotherapy

Cancer

Foods

Hematopoietic stem cell transplantation

Review

Previous article in this issue

Next article in this issue

Front. Biosci. (Landmark Ed) Print ISSN 2768-6701 Electronic ISSN 2768-6698